Wells Fargo & Company MN Reduces Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Wells Fargo & Company MN reduced its stake in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 46.9% in the fourth quarter, Holdings Channel reports. The fund owned 82,820 shares of the biopharmaceutical company’s stock after selling 73,111 shares during the quarter. Wells Fargo & Company MN’s holdings in Catalyst Pharmaceuticals were worth […]
